)
Visual
test
Precipio
Precipio (PRPO) investor relations material
Precipio Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary14 Nov, 2025
Executive summary
Achieved first-ever positive adjusted EBITDA of $469,000 and generated $285,000 in operating cash flow in Q3 2025, marking a strategic shift from break-even focus to growth reinvestment.
Q3 2025 revenue reached $6.8 million, up 30% year-over-year and 20% quarter-over-quarter, with double-digit growth in both Pathology Services and Products Divisions.
Focused on cancer diagnostics, leveraging proprietary technology and CLIA labs in Connecticut and Nebraska to develop and commercialize diagnostic products and services.
Addressed operational disruptions from a Change Healthcare cyberattack and received Employee Retention Credit, both impacting non-recurring income.
Share price has tripled since early 2025, reflecting market confidence in operational and financial progress.
Financial highlights
Q3 2025 revenue was $6.8M, up 30% year-over-year and 20% quarter-over-quarter; nine-month net sales were $17.4M, up 33%.
Gross profit for Q3 2025 was $3.0M (44% margin); Pathology Services margin rose to 46%, while Products Division margin declined to 30% due to growth investments.
Net loss for Q3 2025 was $0.08M; nine-month net loss was $0.9M, a significant improvement from $3.9M loss in 2024.
Adjusted EBITDA was $469,000 in Q3 2025, up from $100,000 a year ago and a loss of $78,000 in Q2 2025.
Operating cash flow was $285,000 in Q3 2025, reversing a $148,000 burn in Q2.
Outlook and guidance
Priorities include sustaining double-digit growth, expanding margins, reinvesting cash into growth initiatives, and increasing share price liquidity through investor engagement.
Expectation to exceed 50% gross margin by mid-2026 as both divisions scale on existing infrastructure.
Full repayment of Change Healthcare obligation by Q1 2026 will further boost operational cash retention.
Substantial doubt remains about the ability to continue as a going concern over the next 12 months without additional revenue growth or financing.
Assessing the impact of the One Big Beautiful Bill Act of 2025 on tax and regulatory environment.
Timeline for Products gross margin recovery?
Post-Q1 2026 cash from operations outlook?
What's the strategy for scalable growth via distributors?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Latest summaries
- TimeTickerHeadlineOpen
- 6 FebHTOO
Resale registration for 71,429 shares via warrant, with proceeds only on exercise; financial risks persist. - 6 FebVSAT
Q3 revenue up 3% to $1.16B, net income $25M, strong cash flow, Ligado boost, satellite focus. - 6 FebWEC
Targets 7–8% EPS growth, $37.5B capex, and coal exit by 2032 amid surging data center demand. - 6 FebBR
Q2 FY26 recurring revenue grew 8% and adjusted EPS guidance was raised to 9-12%. - 6 FebFFWM
Merger vote includes new non-voting stock class with limited conversion and no voting rights. - 6 FebKKR
Charter amendments seek to modernize governance and establish one share, one vote by 2026. - 6 FebARI
Proposed $9B real estate loan portfolio acquisition highlights disciplined, long-term strategy. - 6 FebSMCI
Q2 revenue jumped 123% to $12.7B, with FY26 guidance raised to at least $40B. - 6 FebRJF
Record revenues and assets, higher dividend, and acquisitions despite lower net income. - 6 FebFFIE
Raising capital for global EV and AI expansion, with regulatory and dilution risks highlighted.
Next Precipio earnings date
Q4 202527 Mar, 2026
Precipio
Next Precipio earnings date
Q4 202527 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Precipio, Inc., a cancer diagnostics and reagent technology company, provides diagnostic products and services in the United States oncology market. The company delivers liquid biopsy products for the detection of genomic biomarkers, such as cell-free DNA (cfDNA) extracted from patient blood. Its integrated liquid biopsy platform combines proprietary CFDNA extraction and enrichment technology with third party sample preparation to enable the detection of tumor-specific cfDNA in multiple end-user clinical applications. The company is also involved in development of novel diagnostic products at its laboratories in Tempe and San Diego, California. Precipio, Inc. is based in San Diego, California.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage